Ugovi subcutaneous injection 0.25 mg SD

Ugovi subcutaneous injection 0.25 mg SD (YJ code: 2499418G5023, standard: 0.25mg 0.5mL 1 kit), manufactured by Novo Nordisk Pharma, contains semaglutide (genetical recombination). Often known as Wegovy, this GLP-1 agonist is primarily used for long-term weight management in adults with obesity or overweight and related health conditions, and to reduce the risk of major cardiovascular events.